60 Degrees Pharmaceuticals SXTP Q2 2025 earnings
Reported August 13, 2025 · Before market open
Revenue$100.9KMiss by $49.1K
EPS-$1.25Miss by $0.01
Revenue estimate$150.0K
EPS estimate-$1.24
Next report
Aug 12, 2026 (In 2 weeks)Revenue estimate$185.0K
EPS estimate-$0.74
Versus estimates
Revenue
Diluted EPS
Ask the moment 60 Degrees Pharmaceuticals reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did 60 Degrees Pharmaceuticals report Q2 2025 earnings?
- 60 Degrees Pharmaceuticals (SXTP) reported Q2 2025 earnings on August 13, 2025 before market open.
- What were 60 Degrees Pharmaceuticals's Q2 2025 revenue and EPS?
- 60 Degrees Pharmaceuticals reported revenue of $100.9K and eps of $-1.25 for Q2 2025.
- Did 60 Degrees Pharmaceuticals beat estimates in Q2 2025?
- Revenue missed the consensus estimate of $150.0K by $49.1K. EPS missed the consensus estimate of $-1.24 by $0.01.
- How did 60 Degrees Pharmaceuticals's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 19.2% from $125.0K a year earlier and eps grew 94.1% from $-21.15.
- Where can I find 60 Degrees Pharmaceuticals's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001554855-25-001009) directly on SEC EDGAR. The filing index links above go to sec.gov.